| Literature DB >> 24850345 |
Guillermina Barril1, Juan A Quiroga2, María Dolores Arenas3, Mario Espinosa4, Nuria García-Fernández5, Secundino Cigarrán6, José A Herrero7, Gloria del Peso8, Pilar Caro9, Rebeca García-Agudo10, Yésica Amézquita11, Ana Blanco12, Pilar Martínez-Rubio13, José M Alcázar14, Emilio González-Parra15, Adoración Martín-Gómez16, Inmaculada Castillo2, Javier Bartolomé2, Vicente Carreño17.
Abstract
Amplification of hepatitis C virus (HCV) RNA from blood detected occult HCV infections in 30.9% of 210 HCV-seronegative dialysis patients with abnormal liver enzyme levels that had evaded standard HCV testing practices. Isolated HCV core-specific antibody detection identified three additional anti-HCV screening-negative patients lacking HCV RNA amplification in blood who were considered potentially infectious. Together, these findings may affect management of the dialysis setting.Entities:
Mesh：
Substances：
Year: 2014 PMID： 24850345 PMCID： PMC4136170 DOI： 10.1128/JCM.01339-14
Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948